On Friday, Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) opened higher 4.39% from the last session, before settling in for the closing price of $6.83. Price fluctuations for ARCT have ranged from $5.85 to $24.17 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -6.84%. Company’s average yearly earnings per share was noted 28.22% at the time writing. With a float of $26.02 million, this company’s outstanding shares have now reached $27.23 million.
Arcturus Therapeutics Holdings Inc (ARCT) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Arcturus Therapeutics Holdings Inc is 8.42%, while institutional ownership is 84.64%.
Arcturus Therapeutics Holdings Inc (ARCT) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -1.11 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.49) by -0.62. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.43 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 28.22% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 21.27% during the next five years compared to -6.84% drop over the previous five years of trading.
Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) Trading Performance Indicators
Check out the current performance indicators for Arcturus Therapeutics Holdings Inc (ARCT). In the past quarter, the stock posted a quick ratio of 7.86. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.38.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.46, a number that is poised to hit -0.79 in the next quarter and is forecasted to reach -2.74 in one year’s time.
Technical Analysis of Arcturus Therapeutics Holdings Inc (ARCT)
The latest stats from [Arcturus Therapeutics Holdings Inc, ARCT] show that its last 5-days average volume of 0.87 million was superior to 0.7 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 86.30%.
During the past 100 days, Arcturus Therapeutics Holdings Inc’s (ARCT) raw stochastic average was set at 6.99%, which indicates a significant decrease from 87.07% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.42 in the past 14 days, which was lower than the 1.13 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.70, while its 200-day Moving Average is $13.62. Now, the first resistance to watch is $7.27. This is followed by the second major resistance level at $7.40. The third major resistance level sits at $7.62. If the price goes on to break the first support level at $6.92, it is likely to go to the next support level at $6.70. Assuming the price breaks the second support level, the third support level stands at $6.57.
Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) Key Stats
There are currently 28,413K shares outstanding in the company with a market cap of 202.58 million. Presently, the company’s annual sales total 152,310 K according to its annual income of -80,940 K. Last quarter, the company’s sales amounted to 17,150 K and its income totaled -13,450 K.
